Raxtozinameran
- Generic Name
- Raxtozinameran
- Drug Type
- Biotech
Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
Manufacturer:Pfizer Manufacturing Belgium NV, BioNTech Manufacturing Marburg GmbH, mibe GmbH Arzneimittel
Form:INJECTION
Strength:30 mcg/dose
Online:Yes
Approved: 2024/05/31
Approval:SIN17016P
COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
Manufacturer:Pfizer Manufacturing Belgium NV
Form:INJECTION
Strength:10 μg/dose
Online:Yes
Approved: 2024/05/31
Approval:SIN17017P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath